chr11-66052460-G-T
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_006842.3(SF3B2):c.76G>T(p.Ala26Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00779 in 1,613,678 control chromosomes in the GnomAD database, including 79 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_006842.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SF3B2 | NM_006842.3 | c.76G>T | p.Ala26Ser | missense_variant | 1/22 | ENST00000322535.11 | NP_006833.2 | |
SF3B2 | XM_005273726.5 | c.76G>T | p.Ala26Ser | missense_variant | 1/22 | XP_005273783.1 | ||
SF3B2 | XM_011544740.4 | c.76G>T | p.Ala26Ser | missense_variant | 1/22 | XP_011543042.1 | ||
SF3B2 | XM_017017144.3 | c.76G>T | p.Ala26Ser | missense_variant | 1/22 | XP_016872633.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SF3B2 | ENST00000322535.11 | c.76G>T | p.Ala26Ser | missense_variant | 1/22 | 1 | NM_006842.3 | ENSP00000318861 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00615 AC: 936AN: 152228Hom.: 5 Cov.: 32
GnomAD3 exomes AF: 0.00657 AC: 1640AN: 249662Hom.: 20 AF XY: 0.00705 AC XY: 955AN XY: 135536
GnomAD4 exome AF: 0.00796 AC: 11637AN: 1461334Hom.: 74 Cov.: 34 AF XY: 0.00802 AC XY: 5827AN XY: 726968
GnomAD4 genome AF: 0.00615 AC: 937AN: 152344Hom.: 5 Cov.: 32 AF XY: 0.00592 AC XY: 441AN XY: 74504
ClinVar
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2024 | SF3B2: BS2 - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 09, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at